Artificial Intelligence Predicts Next Session’s Price Change For Xerox Corporation, Bio-Techne Corp, Live Nation Entertainment

(VIANEWS) – Today, the Innrs artificial intelligence algorithm suggests a high probability of discovering the approximate price for tomorrow of Xerox Corporation XRX, Bio-Techne Corp TECH and others.

Via News will regularly fact-check this AI algorithm that aims to consistently predict the next session price and next week’s trend of financial assets.

Innrs provides A.I.-based statistical tools to help investors make decisions. The table below shows the financial assets predicting price, ordered by the highest expected accuracy.

Innrs officials say this tool helps investors make better-informed decisions, supposedly used alongside other relevant financial information and the specific trader strategy.

In the next session, Via News will report the finding on the algorithm precision.

1. Xerox Corporation (XRX)

Shares of Xerox Corporation fell by a staggering 10.66% in from $17 to $15.19 at 19:21 EST on Monday, after three consecutive sessions in a row of losses. NYSE is rising 0.68% to $15,318.08, after three successive sessions in a row of gains.

Xerox Holdings Corporation, a workplace technology company, designs, develops, and sells document management systems and solutions in the Americas, Europe, the Middle East, Africa, India, and internationally. It offers workplace solutions, including desktop monochrome, and color and multifunction printers; digital printing presses and light production devices, and solutions; and digital services that leverage workflow automation, personalization and communication software, content management solutions, and digitization services. The company also provides graphic communications and production solutions; and IT services, end user computing devices, network infrastructure, communications technology, and a range of managed IT solutions, such as technology product support, professional engineering, and commercial robotic process automation; and provides finance for the sale of Xerox, non-Xerox office, and IT services equipment. In addition, it provides FreeFlow a portfolio of software solutions for the automation and integration to the processing of print job comprises file preparation, final production, and electronic publishing. Further, the company sells paper products and wide-format systems, licensing, as well as standalone software such as CareAR, DocuShare, and XMPie. The company sells its products and services directly to its customers through its direct sales force, as well as through independent agents, dealers, value-added resellers, systems integrators, and e-commerce marketplaces. Xerox Holdings Corporation was founded in 1906 and is headquartered in Norwalk, Connecticut.

Sales Growth

Xerox Corporation’s sales growth is negative 1% for the current quarter and negative 4.1% for the next.

Moving Average

Xerox Corporation’s worth is under its 50-day moving average of $15.79 and under its 200-day moving average of $15.49.

Yearly Top and Bottom Value

Xerox Corporation’s stock is valued at $15.19 at 19:21 EST, way under its 52-week high of $18.00 and way above its 52-week low of $11.80.

More news about Xerox Corporation.

2. Bio-Techne Corp (TECH)

Shares of Bio-Techne Corp fell 4.39% in from $71.25 to $68.12 at 19:21 EST on Monday, after three consecutive sessions in a row of gains. NASDAQ is jumping 0.39% to $13,484.24, following the last session’s upward trend.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 1.14B for the twelve trailing months.

Moving Average

Bio-Techne Corp’s worth is way below its 50-day moving average of $76.03 and way below its 200-day moving average of $78.68.

More news about Bio-Techne Corp.

3. Live Nation Entertainment (LYV)

Shares of Live Nation Entertainment rose 6.22% in from $82.05 to $87.15 at 19:21 EST on Monday, after three consecutive sessions in a row of gains. NYSE is jumping 0.68% to $15,318.08, after three consecutive sessions in a row of gains.

Live Nation Entertainment, Inc. operates as a live entertainment company. It operates through Concerts, Ticketing, and Sponsorship & Advertising segments. The Concerts segment promotes live music events in its owned or operated venues, and in rented third-party venues; operates and manages music venues; produces music festivals; creates and streams associated content; and offers management and other services to artists. The Ticketing segment manages the ticketing operations, including the provision of ticketing software and services to clients for tickets and event information through its primary websites livenation.com and ticketmaster.com, as well as through other websites, mobile apps, retail outlets, and call centers; and provides ticket resale services. This segment sells tickets for its events and third-party clients in various live event categories; offers ticketing services for arenas, stadiums, amphitheaters, music clubs, concert promoters, professional sports franchises and leagues, college sports teams, performing arts venues, museums, and theaters. The Sponsorship & Advertising segment sells international, national, and local sponsorships and placement of advertising, including signage and promotional programs; rich media offering that comprise advertising related with live streaming and music-related content; and ads across its distribution network of venues, events, and websites. This segment also manages the development of strategic sponsorship programs, as well as develops, books, and produces custom events or programs for specific brands. It owns, operates, or leases entertainment venues in North America and internationally. The company was formerly known as Live Nation, Inc. and changed its name to Live Nation Entertainment, Inc. in January 2010. Live Nation Entertainment, Inc. was incorporated in 2005 and is headquartered in Beverly Hills, California.

Sales Growth

Live Nation Entertainment’s sales growth is 36% for the current quarter and 7.2% for the next.

Moving Average

Live Nation Entertainment’s value is above its 50-day moving average of $84.21 and above its 200-day moving average of $79.29.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 8.6% and a negative 9.2%, respectively.

Volatility

Live Nation Entertainment’s last week, last month’s, and last quarter’s current intraday variation average was 0.32%, 0.28%, and 1.16%.

Live Nation Entertainment’s highest amplitude of average volatility was 1.51% (last week), 1.36% (last month), and 1.16% (last quarter).

More news about Live Nation Entertainment.

4. CME Group (CME)

Shares of CME Group jumped 4.07% in from $205.85 to $214.23 at 19:21 EST on Monday, after four sequential sessions in a row of gains. NASDAQ is jumping 0.39% to $13,484.24, following the last session’s upward trend.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 11.1% and 10.4%, respectively.

Yearly Top and Bottom Value

CME Group’s stock is valued at $214.23 at 19:21 EST, above its 52-week high of $212.43.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CME Group’s stock is considered to be oversold (<=20).

Moving Average

CME Group’s value is higher than its 50-day moving average of $203.65 and way higher than its 200-day moving average of $187.89.

More news about CME Group.

5. Burlington Stores (BURL)

Shares of Burlington Stores slid by a staggering 30.15% in from $171.55 to $119.83 at 19:21 EST on Monday, following the last session’s upward trend. NYSE is rising 0.68% to $15,318.08, after three consecutive sessions in a row of gains.

Burlington Stores, Inc. operates as a retailer of branded apparel products in the United States. The company provides fashion-focused merchandise, including women's ready-to-wear apparel, menswear, youth apparel, footwear, accessories, toys, gifts, and coats, as well as baby, home, and beauty products. It operates stores under the Burlington Stores, and Cohoes Fashions brand names in Puerto Rico. Burlington Stores, Inc. was founded in 1972 and is headquartered in Burlington, New Jersey.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 130.2% and 9.5%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 9.09B for the twelve trailing months.

Sales Growth

Burlington Stores’s sales growth for the next quarter is 10.8%.

Volatility

Burlington Stores’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.77%, a negative 1.19%, and a positive 1.88%.

Burlington Stores’s highest amplitude of average volatility was 2.70% (last week), 2.15% (last month), and 1.88% (last quarter).

More news about Burlington Stores.

6. Graham Holdings Company (GHC)

Shares of Graham Holdings Company rose 2.72% in from $576.42 to $592.10 at 19:21 EST on Monday, following the last session’s downward trend. NYSE is rising 0.68% to $15,318.08, after three sequential sessions in a row of gains.

Graham Holdings Company, through its subsidiaries, operates as a diversified education and media company in the United States and internationally. It provides test preparation services and materials; professional training and exam preparation for professional certifications and licensures; and non-academic operations support services to the Purdue University Global; operations support services for online courses and programs; training and test preparation services for accounting and financial services professionals; English-language training, academic preparation programs, and test preparation for English proficiency exams; and A-level examination preparation services, as well as operates colleges, business school, higher education institution, and an online learning institution. The company also owns and operates television stations, restaurants, and entertainment venues; engages in the financial training and automobile dealerships business; offers social media management tools to connect newsrooms with their users; produces Foreign Policy magazine and ForeignPolicy.com website; and publishes Slate, an online magazine, as well as French-language news magazine websites at slate.fr and slateafrique.com. In addition, it provides social media marketing solutions; home health, hospice, and palliative services; burners, igniters, dampers, and controls; screw jacks, linear actuators, and related linear motion products, and lifting systems; pressure impregnated kiln-dried lumber and plywood products; digital advertising services; power charging and data systems, industrial and commercial indoor lighting solutions, and electrical components and assemblies; dermatology and professional aesthetics, and skin care services; software and services; and operates pharmacy. The company was formerly known as The Washington Post Company and changed its name to Graham Holdings Company in November 2013. Graham Holdings Company was founded in 1877 and is based in Arlington, Virginia.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 49.5% and a negative 33.4%, respectively.

More news about Graham Holdings Company.

7. Alnylam Pharmaceuticals (ALNY)

Shares of Alnylam Pharmaceuticals dropped by a staggering 21.93% in from $213.07 to $166.34 at 19:21 EST on Monday, following the last session’s downward trend. NASDAQ is rising 0.39% to $13,484.24, following the last session’s upward trend.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; ALN-AAT02 for the treatment of AAT deficiency-associated liver disease; ALN-HBV02 to treat chronic HBV infection; Zilebesiran to treat hypertension; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia and rare bleeding disorders, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1 and recurrent renal stones, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Volatility

Alnylam Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.27%, a negative 0.71%, and a positive 1.70%.

Alnylam Pharmaceuticals’s highest amplitude of average volatility was 3.09% (last week), 2.50% (last month), and 1.70% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Alnylam Pharmaceuticals’s stock is considered to be oversold (<=20).

More news about Alnylam Pharmaceuticals.

8. Biogen (BIIB)

Shares of Biogen jumped 1.57% in from $258.74 to $262.80 at 19:21 EST on Monday, after three consecutive sessions in a row of gains. NASDAQ is jumping 0.39% to $13,484.24, following the last session’s upward trend.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; ADUHELM to treat Alzheimer's disease; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE; and BYOOVIZ, a ranibizumab biosimilar referencing LUCENTIS. It also provides RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for non-Hodgkin's lymphoma; and other anti-CD20 therapies. In addition, the company is developing various products for the treatment of MS, Alzheimer's disease and dementia, neuromuscular disorders, Parkinson's disease and movement disorders, neuropsychiatry, immunology related diseases, neurovascular disorders, genetic neurodevelopmental disorders, and biosimilars, which are under various stages of development. Biogen Inc. has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis Co., Ltd.; Sangamo Therapeutics, Inc.; and Sage Therapeutics, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Biogen’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 17% and a negative 4.7%, respectively.

Sales Growth

Biogen’s sales growth is negative 5.1% for the present quarter and negative 6.3% for the next.

More news about Biogen.

9. Ross Stores (ROST)

Shares of Ross Stores slid 5.49% in from $119.5 to $112.94 at 19:21 EST on Monday, following the last session’s upward trend. NASDAQ is rising 0.39% to $13,484.24, following the last session’s upward trend.

Ross Stores, Inc., together with its subsidiaries, operates off-price retail apparel and home fashion stores under the Ross Dress for Less and dd's DISCOUNTS brand names in the United States. Its stores primarily offer apparel, accessories, footwear, and home fashions. The company's Ross Dress for Less stores sell its products at department and specialty stores primarily to middle income households; and dd's DISCOUNTS stores sell its products at department and discount stores for households with moderate income. Ross Stores, Inc. was incorporated in 1957 and is headquartered in Dublin, California.

Moving Average

Ross Stores’s worth is below its 50-day moving average of $115.66 and above its 200-day moving average of $110.95.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ross Stores’s stock is considered to be overbought (>=80).

More news about Ross Stores.

10. Zillow Group (Z)

Shares of Zillow Group dropped by a staggering 18.16% in from $53.16 to $43.51 at 19:21 EST on Monday, following the last session’s upward trend. NASDAQ is jumping 0.39% to $13,484.24, following the last session’s upward trend.

Zillow Group, Inc. operates real estate brands on mobile applications and Websites in the United States. The company operates through Internet, Media & Technology (IMT); Mortgages; and Homes segments. Its IMT segment offers premier agent and rentals marketplaces, as well as other services, which includes new construction marketplace, advertising, and business technology solutions, as well as display and dotloop and floor plans. The company's Mortgages segment provides mortgage originations and the sale of mortgages, and advertising to mortgage lenders and other mortgage services. Its Homes segment offers title and escrow services. The company's brand portfolio includes Zillow Premier Agent, Zillow Home Loans, Zillow Closing Services, Zillow Rentals, Trulia, StreetEasy, HotPads, and Out East; and Mortech, a suite of marketing software and technology solutions for the real estate industry, as well as New Home Feed and ShowingTime+, and Bridge Interactive. Zillow Group, Inc. was incorporated in 2004 and is headquartered in Seattle, Washington.

More news about Zillow Group.

11. Sabre Corporation (SABR)

Shares of Sabre Corporation slid by a staggering 28.72% in from $5.27 to $3.76 at 19:21 EST on Monday, following the last session’s upward trend. NASDAQ is jumping 0.39% to $13,484.24, following the last session’s upward trend.

Sabre Corporation, through its subsidiaries, provides software and technology solutions for the travel industry worldwide. It operates in two segments, Travel Solutions and Hospitality Solutions. The Travel Solutions segment operates a business-to-business travel marketplace that offers travel content, such as inventory, prices, and availability from a range of travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise lines, and tour operators with a network of travel buyers comprising online and offline travel agencies, travel management companies, and corporate travel departments. This segment also provides a portfolio of software technology products and solutions through software-as-a-service (SaaS) and hosted delivery models to airlines and other travel suppliers. Its products include reservation systems for carriers, commercial and operations products, agency solutions, and data-driven intelligence solutions. The Hospitality Solutions segment provides software and solutions to hoteliers through SaaS and hosted delivery models. Sabre Corporation was incorporated in 2006 and is headquartered in Southlake, Texas.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 76% and 86.8%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.2%, now sitting on 2.77B for the twelve trailing months.

More news about Sabre Corporation.

12. Globalstar (GSAT)

Shares of Globalstar dropped 7.14% in from $1.51 to $1.40 at 19:21 EST on Monday, after five successive sessions in a row of gains. NYSE is jumping 0.68% to $15,318.08, after three consecutive sessions in a row of gains.

Globalstar, Inc. provides mobile satellite services worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational usage, safety, emergency preparedness and response, and other applications. It also provides one-way or two-way communications and data transmissions using mobile devices, including the SPOT family of products, such as SPOT X, SPOT Gen4, and SPOT Trace that transmit messages and the location of the device; commercial Internet of Things transmission products to track cargo containers and rail cars, as well as to monitor utility meters, and oil and gas assets; small satellite transmitter modules, such as the STX-3, ST-150 and ST100, and chips that enable an integrator's products to access company's network; and engineering and other communication services using MSS and terrestrial spectrum licenses, as well as undertakes installation of gateways and antennas. The company distributes its products through retailers, sales force, and e-commerce website. Globalstar, Inc. serves recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, construction, utilities, and transportation, as well as natural resources, mining, and forestry markets. The company was founded in 1993 and is headquartered in Covington, Louisiana.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Globalstar’s stock is considered to be oversold (<=20).

Volatility

Globalstar’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.44%, a negative 0.39%, and a positive 3.04%.

Globalstar’s highest amplitude of average volatility was 3.44% (last week), 2.96% (last month), and 3.04% (last quarter).

More news about Globalstar.

13. Cadence Design Systems (CDNS)

Shares of Cadence Design Systems jumped 1.86% in from $243.01 to $247.53 at 19:21 EST on Monday, following the last session’s upward trend. NASDAQ is jumping 0.39% to $13,484.24, following the last session’s upward trend.

Cadence Design Systems, Inc. provides software, hardware, services, and reusable integrated circuit (IC) design blocks worldwide. The company offers functional verification services, including emulation and prototyping hardware. Its functional verification offering consists of JasperGold, a formal verification platform; Xcelium, a parallel logic simulation platform; Palladium, an enterprise emulation platform; and Protium, a prototyping platform for chip verification. The company also provides digital IC design and sign off products, including Genus logic synthesis and Joules RTL power solutions, as well as Modus software solution to reduce systems-on-chip design-for-test time; physical implementation tools, such as place and route, optimization, and multiple patterning preparation; and Innovus implementation system, a physical implementation system. In addition, it offers custom IC design and simulation products to create schematic and physical representations of circuits down to the transistor level for analog, mixed-signal, custom digital, memory, and radio frequency designs; and system design and analysis products to develop printed circuit boards and IC packages, as well as to analyze electromagnetic, electro-thermal, and other multi-physics effects. Further, the company provides intellectual property (IP) products comprising pre-verified and customizable functional blocks to integrate into customer's ICs; and verification IP with memory models to emulate and model the expected behavior and interaction of standard industry system interface protocols. Additionally, it offers services related to methodology, education, and hosted design solutions, as well as technical support and maintenance services. The company serves 5G communications, aerospace and defense, automotive, industrial and healthcare, mobile, consumer, and hyperscale computing markets. Cadence Design Systems, Inc. was incorporated in 1987 and is headquartered in San Jose, California.

Volatility

Cadence Design Systems’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.25%, a negative 0.08%, and a positive 1.23%.

Cadence Design Systems’s highest amplitude of average volatility was 2.10% (last week), 1.46% (last month), and 1.23% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 13.2% and 42.7%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Cadence Design Systems’s stock is considered to be oversold (<=20).

Moving Average

Cadence Design Systems’s value is above its 50-day moving average of $233.18 and way higher than its 200-day moving average of $212.18.

More news about Cadence Design Systems.

14. E.I. du Pont de Nemours and Company (DD)

Shares of E.I. du Pont de Nemours and Company dropped 0.84% in from $76.03 to $75.39 at 19:21 EST on Monday, following the last session’s upward trend. NYSE is rising 0.68% to $15,318.08, after three consecutive sessions in a row of gains.

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits addressing various steps of the manufacturing process. This segment also provides semiconductor and advanced packaging materials; dielectric and metallization solutions for chip packaging; and silicones for light emitting diode packaging and semiconductor applications; permanent and process chemistries for the fabrication of printed circuit boards to include laminates and substrates, and electroless and electrolytic metallization solutions, as well as patterning solutions, and materials and metallization processes for metal finishing, decorative, and industrial applications. In addition, it offers various materials to manufacture rigid and flexible displays for organic light emitting diode, and other display applications, as well as provides high performance parts, and specialty silicone elastomers, and lubricants to automotive, aerospace, electronics, industrial, and healthcare markets. The Water & Protection segment provides engineered products and integrated systems for worker safety, water purification and separation, transportation, energy, medical packaging and building materials. The Corporate & Other segment offers auto adhesives and fluids; Multibase; and Tedlar products. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.

More news about E.I. du Pont de Nemours and Company.

15. Electronic Arts (EA)

Shares of Electronic Arts rose 1.08% in from $122.77 to $124.10 at 19:21 EST on Monday, after three successive sessions in a row of gains. NASDAQ is jumping 0.39% to $13,484.24, following the last session’s upward trend.

Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets worldwide. It develops and publishes games and services across various genres, such as sports, racing, first-person shooter, action, role-playing, and simulation primarily under the Battlefield, The Sims, Apex Legends, Need for Speed, and license games from others, including FIFA, Madden NFL, UFC, and Star Wars brands. The company licenses its games to third parties to distribute and host its games. It markets and sells its games and services through digital distribution and retail channels, as well as directly to mass market retailers, specialty stores, and distribution arrangements. Electronic Arts Inc. was incorporated in 1982 and is headquartered in Redwood City, California.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.9%, now sitting on 7.58B for the twelve trailing months.

Sales Growth

Electronic Arts’s sales growth for the current quarter is negative 1.6%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Electronic Arts’s stock is considered to be oversold (<=20).

More news about Electronic Arts.